women with cervicitis. Inflammatory disease of cervix uteri
Conditions
Interventions
Intervention 1: In the intervention group, for the treatment of cervicitis, an amnion membrane (amniodisc of Sinacell company) is used as a one-time placement of the dressing in the affected area and
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 45 Years
Inclusion criteria
Inclusion criteria: Married women between 25-45 years old with chronic cervicitis who are not menstruating Absence of underlying disease such as diabetes, blood pressure, autoimmune diseases Having normal colposcopy results and not having HPV and acute infection Absence of substance abuse Not taking OCP and drugs that weaken the immune system (corticosteroid drugs) Not using an IUD
Exclusion criteria
Exclusion criteria: Unwillingness to continue participating in the study sensitive reaction to amniotic membrane or medical treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptom of cervicitis including vaginal discharge, vaginal itching, post coital bleeding, pelvic pain. Timepoint: one month after intervention. Method of measurement: medical history.;Para clinical symptom of cervicitis including colposcopic visualization. Timepoint: one month after intervention. Method of measurement: colposcopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changing the size of the cervical wound. Timepoint: one month after intervention. Method of measurement: colposcopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHanieh Najafiarab
Shahid Beheshti University of Medical Sciences
Outcome results
None listed